Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-015417
Filing Date
2018-11-08
Accepted
2018-11-08 08:01:33
Documents
67
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 443550
2 ex10-1.htm EX-10.1 259280
3 ex31-1.htm EX-31.1 20536
4 ex31-2.htm EX-31.2 20334
5 ex32-1.htm EX-32.1 7268
6 ex32-2.htm EX-32.2 7222
  Complete submission text file 0001493152-18-015417.txt   3497666

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE crbp-20180930.xml EX-101.INS 439840
8 XBRL SCHEMA FILE crbp-20180930.xsd EX-101.SCH 49788
9 XBRL CALCULATION FILE crbp-20180930_cal.xml EX-101.CAL 54031
10 XBRL DEFINITION FILE crbp-20180930_def.xml EX-101.DEF 176184
11 XBRL LABEL FILE crbp-20180930_lab.xml EX-101.LAB 333145
12 XBRL PRESENTATION FILE crbp-20180930_pre.xml EX-101.PRE 256172
Mailing Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

EIN.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37348 | Film No.: 181168228
SIC: 2834 Pharmaceutical Preparations